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Abstract 
 
Reactive plasmacytosis is a transient expansion of plasma cell progenitors and 
precursors. This rare condition has been reported mainly in infections and tumors. Here 
we describe a case of acute hepatitis A presenting with marked peripheral blood 
plasmacytosis. Plasma cells comprised 27.5% of mononuclear cells, and had the 
immunophenotype CD10-CD19+CD20-CD21-CD23-CD34-CD38++HLA-DR+. Although 
the level of interleukin-6 was not increased, the presence of activated T cells with an 
inverted CD4/CD8 ratio and high levels of soluble interleukin-2 receptor and neopterin 
indicated a marked immune response to acute hepatitis A. The patient’s plasma cells had 
almost disappeared from the blood by hospital day 16. This report may represent the first 




Reactive peripheral blood plasmacytosis is a transient expansion of benign 
polyclonal plasma cells in the circulation [1,2]. It is an uncommon clinical finding that 
has been associated with infections, autoimmune disorders, and neoplastic diseases [2]. 
Because of the rarity of the condition, the biology of reactive plasmacytosis remains 
undefined.  
Acute hepatitis A is one of the most common infectious diseases [3]. Hepatitis A 
usually affects children without producing symptoms, but in adults it causes clinically 
apparent disease with jaundice. Extrahepatic, hematological manifestations of acute 
hepatitis A infection are rare [3], and plasmacytosis has not been described. In this report, 
we describe a patient with acute hepatitis A who developed extreme, transient peripheral 
blood plasmacytosis.  
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2. Case report 
 
A 14-year-old Japanese male was referred to our hospital for evaluation of 
elevated liver enzymes. He had fever of 5 days’ duration, malaise, and decreased appetite. 
Although his grandmother suffered from chronic hepatitis C infection, the patient had no 
history of liver disease. There was also no past history of allergic diseases and 
hypersensitivity to medicine. His liver was palpable 1.5 cm below the right subcostal 
margin, but the spleen was impalpable. He had no right upper quadrant tenderness. The 
rest of his physical examination was unremarkable. Laboratory studies revealed a WBC 
count of 3,500/μL, a hemoglobin level of 15.5 g/dL, and a platelet count of 13.1 x 106/μL. 
The differential leukocyte count included 50% neutrophils, 7% eosinophils, 1% basophils, 
1% myelocytes, 31% lymphocytes, 2% atypical lymphocytes, and 8% monocytes. His 
liver enzymes were: aspartate aminotransferase (AST) 1,429 IU/L (normal 10-48); 
alanine aminotransferase (ALT) 2,308 IU/L (normal 3-50); total bilirubin (T-Bil) 
2.4 mg/dL (normal 0.2-1.3) with direct fraction 1.4 mg/dL; alkaline phosphatase 
750 IU/L (normal 108-324); γ-glutamyl transpeptidase 356 IU/L (normal 11-48); 
prothrombin time 15.6 seconds (normal 9.4-11.1); and hepaplastin test 40% (normal 84-
158). A serum concentration of C-reactive protein (CRP) was 5.6 mg/dL. 
Immunoglobulin (Ig) levels were normal (IgG 1,260 mg/dL, IgA 188 mg/dL, IgM 
182 mg/dL), and a monoclonal protein was not detected by serum protein electrophoresis. 
A hepatitis A IgM antibody test was positive (2.8; normal ≤ 0.8) on hospital day 2. 
Evaluation was negative for other infectious hepatitis including Epstein-Barr virus, 
cytomegalovirus, parvovirus B19, and viral hepatitis B and C. 
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 As part of the clinical assessment, we performed fluorescence-activated cell 
sorting (FACS) analysis of peripheral blood lymphocytes [4]. As shown in Table 1, on 
hospital day 2 the ratio of CD4+ to CD8+ T cells was markedly inverted and the majority 
of CD4+ and CD8+ T cells expressed CD45R0, indicating an activated phenotype. 
Additionally, the level of soluble interleukin (IL)-2 receptor in the patient’s serum was 
elevated at 3,980 IU/mL (normal 230-550). More importantly, an unusual mononuclear 
cell subset of CD19+CD20- cells was significantly increased, with larger cells 
predominating (Figure 1A). Interestingly, CD19 expression was relatively low in these 
cells compared with CD19+CD20+ B cells. Multicolor FACS analysis revealed that they 
did not express CD10, CD21, CD23, CD33, or CD34, whereas expression of HLA-DR, 
surface IgM, and κ or λ chains was positive. In addition, CD38 was brightly expressed. 
These findings, together with observations of peripheral blood smears (Figure 1B), 
indicated they were plasma cells. Levels of plasma cytokines including IL-2, IL-6, IL-18, 
interferon-γ, and tumor necrosis factor-α were within normal limits on hospital day 2, 
except for neopterin (26 nmol/L; normal 2-8). Bone marrow aspirate on hospital day 3 
showed normocellular marrow with 2.0% plasma cells and no evidence of malignancy. 
 The patient’s fever diminished during the first few days in hospital, and his liver 
enzymes had almost returned to normal within 18 days of hospitalization. The 
percentages of CD19+CD20- cells and activated T cells decreased with the course of the 
acute hepatitis A (Table 1). 
Approval for the study was obtained from the Human Research Committee of 
Kanazawa University Graduate School of Medical Science, and informed consent was 




 Plasma cells are terminally differentiated B cells specialized for antibody 
secretion. Following antigen activation in secondary lymphoid organs, memory B cells 
differentiate into plasmablasts that migrate into the bone marrow and finally develop into 
plasma cells [5]. Plasmablasts represent less than 0.1% of peripheral blood mononuclear 
cells, and plasma cells are usually undetectable in the peripheral circulation [6]. Although 
peripheral blood plasmacytosis is mostly a manifestation of plasma cell dyscrasias, 
reactive plasmacytosis has occasionally been described in a variety of conditions: tumors, 
autoimmune disorders, and infectious diseases including sepsis, primary infection and 
reactivation of Epstein-Barr virus, acute respiratory infections, parvovirus B19 infection, 
and dengue fever [1,2,7-11].  
In this report, we describe an unusual case of acute hepatitis A presenting with 
reactive peripheral blood plasmacytosis. Reactive plasmacytosis is associated with 
increased levels of inflammatory cytokines, mainly IL-6, an important growth and 
survival factor for nonmalignant and malignant plasma cells [12]. Although serum levels 
of IL-6 have been reported to be significantly increased in patients with acute viral 
hepatitis A, B, and C [13], our patient showed no excess of IL-6. The rapid clearance of 
circulating IL-6 might have occurred in the patient. We also speculate that cytokines 
other than IL-6 could be involved in the development of plasmacytosis, as the IL-6 
receptor subunit glycoprotein 130 is shared with receptors of IL-11, oncostatin M, 
leukemia inhibitory factor, and ciliary neutrophic factor [14]. In particular, IL-11 has 
been detected as a growth factor of IL-6-dependent plasmacytoma [15], and IL-10 has 
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been reported to stimulate myeloma cells via oncostatin M [14]. However, other 
immunological markers such as lymphocyte subsets, soluble IL-2 receptor, and neopterin 
clearly indicated a marked systemic inflammatory response, which might have led to 
plasmacytosis and severe liver dysfunction in the patient. Although the patient was 
considered to have severe course of acute hepatitis A based on his liver parameters, the 
recovery process of the illness was unremarkable. 
A number of changes in B-cell surface molecules have been identified upon 
plasma cell differentiation: CD19, CD20, CD21, CD22, and CD45 decrease in amount, 
whereas CD38 and CD138 increase [5]. Our FACS analysis of the patient’s plasma cells 
is in good agreement with previous reports demonstrating that reactive plasmacytosis is a 
transient expansion of plasmablasts (plasma cell progenitors) and early plasma cells 
(plasma cell precursors) [1,2]. Plasmablasts are proliferating cells that are committed to 
becoming plasma cells, and early plasma cells are nondividing Ig-secreting cells 
committed to entering bone marrow and further maturing [2]. The surface phenotype of 
our patient’s plasma cells was CD10-CD19+CD20-CD21-CD23-CD34-CD38++HLA-
DR+, a common phenotype among plasmablasts and early plasma cells, although we did 
not analyze CD138 expression, by which plasmablasts may be discriminated from early 
plasma cells [1]. Recent studies have shown that these cells are highly susceptible to 
apoptosis through their expression of high levels of CD95 but low levels of Bcl-2 [16]. 
Accelerated apoptosis might have been associated with the rapid and spontaneous 
elimination of  CD19+CD20- cells in the patient and the absence of accumulation of 
plasma cells in his bone marrow.  
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In summary, our results demonstrate that hepatitis A virus may be able to trigger 
an expansion of plasmablasts in vivo and provide important insights into the biology of 
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Table 1. Laboratory features of the patient.  
 
  Hospital day   Normal range 
    day 2  day 6  day 16   
Absolute blood count (/μL) 
       WBC   4,900  5,100  4,500  4,500-11,000 
       Lymphocytes  1,862  2,052  1,994  1,500-3,000 
Lymphocyte subsets (%) 
       CD3+   73.2  70.8  66.2  69.5±4.6 
       CD4+   17.3  29.4  35.7  43.1±6.0 
       CD8+   48.8  36.7  26.9  22.0±5.4 
       CD16+   4.5  16.8  16.3  8.0±4.4 
       CD20+   2.8  7.5  8.0  11.2±3.5 
       TCRγδ+   1.1  2.0  2.8  4.4±2.4 
       CD45R0+ in CD4+ 66.8  62.9  57.9  28.7±9.2 
       CD45R0+ in CD8+ 86.6  66.5  35.6  19.6±10.0 
       CD19+CD20-*  27.5 (685) 7.2 (114) 0.8 (15) < 0.2 
(absolute number, /μL) 
Other 
       AST (IU/L)  1,000  208  41  10-48 
       ALT (IU/L)  2,149  988  155  3-50 
       T-Bil (mg/dL)  3.2  7.0  1.3  0.2-1.3 
       CRP (mg/dL)  NA  0.8  NA  < 0.3 
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*Percentage of cells defined in relation to total population of mononuclear cells. NA 




Figure 1. Characterization of the patient’s plasma cells. A, FACS analysis of peripheral 
blood. A region of mononuclear cells was gated for the fluorescence analysis. Red 
indicates CD19+CD20- cells. B, Peripheral blood smears. May-Grünewald-Giemsa 
staining, original magnification x 400. Arrow indicates plasmablasts.  
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Figure 1. 
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